Exit
Register
Login
2024 PACC Miami | Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer
Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer
Finish Course
You need to enroll in this course to view this chapter
Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer
Enroll
0% Course Complete